Equity-Based Compensation (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock Option Activity Transactions |
The following is a summary of the stock option transactions as of and for the three and six months ended June 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | | Stock Options Outstanding | | (amounts in thousands, except shares and per share amount) | Shares Subject to Options Outstanding | | Weighted- Average Exercise Price per Option | | Weighted- Average Remaining Contractual Terms (in years) | | Aggregate Intrinsic Value | | Balances as of December 31, 2025 | 7,408,212 | | $ | 17.05 | | | 5.28 | | $ | 20,001 | | | Options granted | — | | — | | | | | | | Options exercised | (137,087) | | 15.85 | | | | | | | Options forfeited / expired | (216,537) | | 18.00 | | | | | | | Balances as of March 31, 2026 | 7,054,588 | | 17.05 | | | 5.03 | | 6,477 | | | Options granted | — | | — | | | | | | | Options exercised | (231,672) | | 16.96 | | | | | | | Options forfeited / expired | (3,400) | | 18.00 | | | | | | | Balances as of June 30, 2026 | 6,819,516 | | 17.05 | | | 4.78 | | 46,106 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Vested and Exercisable as of June 30, 2026 | 6,810,562 | | $ | 17.09 | | | 4.78 | | $ | 46,002 | |
|
| Schedule of Restricted Stock Transactions |
The following is a summary of RSU transactions as of and for the three and six months ended June 30, 2026: | | | | | | | | | | | | | | Restricted Stock Units | | Weighted-Average Grant Date Fair Value | | Unvested and outstanding as of December 31, 2025 | 9,356,689 | | $ | 10.49 | | | Granted | 2,613,707 | | 17.21 | | Vested | (2,699,553) | | 8.91 | | Forfeited | (286,686) | | 11.97 | | Balances as of March 31, 2026 | 8,984,157 | | $ | 12.87 | | | Granted | 284,324 | | 15.02 | | Vested | (275,453) | | 13.40 | | Cancelled/forfeited | (111,702) | | 12.31 | | Unvested and outstanding as of June 30, 2026 | 8,881,326 | | $ | 12.93 | | | | | | | | | | | | | | | | | |
|
| Schedule of Earned PSUs in Volume Weighted Average Price Per Share |
The PSUs will become earned (“Earned PSUs”) in three tranches based on the achievement of the following volume-weighted average price per share goals during the Measurement Period (the “Stock Price Hurdles”): | | | | | | | | | | Price Per Share Goals | Number of Earned PSUs | | First Stock Price Hurdle | $33.75 | 333,333 | | Second Stock Price Hurdle | $44.00 | 333,333 | | Third Stock Price Hurdle | $55.25 | 333,334 |
|
| Schedule of PSUs Transactions |
The following is a summary of PSU transactions for the three and six months ended June 30, 2026: | | | | | | | | | | | | | | Performance-based restricted stock units | | Weighted-Average Grant Date Fair Value | | Unvested and outstanding as of December 31, 2025 | 1,685,407 | | $ | 9.35 | | | Granted | 1,792,525 | | 15.62 | | | Vested | — | | — | | | Forfeited | — | | — | | | Unvested and outstanding as of March 31, 2026 | 3,477,932 | | $ | 12.58 | | | Granted | 210,526 | | 14.25 | | | Vested | — | | — | | | Cancelled/forfeited | — | | — | | | Unvested and outstanding as of June 30, 2026 | 3,688,458 | | $ | 12.68 | | | | | | | | | | | | | | | | | |
|
| Schedule of Equity-Based Compensation Expense of Operation |
Total equity-based compensation expense was presented on the statement of operations as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | (amounts in thousands) | 2026 | | 2025 | | 2026 | | 2025 | | Selling, general and administrative expenses | $ | 16,281 | | | $ | 13,959 | | | $ | 28,889 | | | $ | 29,994 | | | Medical expenses | 1,893 | | | 1,594 | | | 3,304 | | | 2,746 | | | Total equity-based compensation expense | $ | 18,174 | | | $ | 15,553 | | | $ | 32,193 | | | $ | 32,740 | |
|